細胞治療技術の世界市場予測（～2023年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.2.1 MARKETS COVERED 15
1.2.2 YEARS CONSIDERED FOR THE STUDY 15
1.3 CURRENCY 16
1.4 LIMITATIONS 16
1.5 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.1.1 SECONDARY DATA 18
2.1.1.1 Key data from secondary sources 18
2.1.2 PRIMARY DATA 19
2.1.2.1 Key data from primary sources 20
2.2 MARKET SIZE ESTIMATION 21
2.2.1 BOTTOM-UP APPROACH 21
2.2.2 TOP-DOWN APPROACH 22
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.4 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 29
4.1 CELL THERAPY INSTRUMENTS: MARKET OVERVIEW 29
4.2 CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT & CELL TYPES (2018) 30
4.3 GEOGRAPHICAL SNAPSHOT OF THE CELL THERAPY INSTRUMENTS MARKET 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 DRIVERS 33
5.2.1.1 Rising government investments in cell-based research 33
5.2.1.2 Large number of oncology-oriented cell-based therapy clinical trials 33
5.2.1.3 Affordability and sustainability of advanced cell therapy instruments 34
5.2.2 RESTRAINTS 34
5.2.2.1 High cost of cell-based research and low success rate 34
5.2.3 OPPORTUNITIES 35
5.2.3.1 Emerging countries 35
6 CELL THERAPY INSTRUMENTS MARKET, BY PRODUCT 36
6.1 INTRODUCTION 37
6.2 CONSUMABLES 38
6.2.1 CONSUMABLES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL THERAPY INSTRUMENTS MARKET DURING THE FORECAST PERIOD 38
6.3 EQUIPMENT 39
6.3.1 CELL PROCESSING EQUIPMENT 40
6.3.1.1 Cell processing equipment are essential in laboratories and institutes for conducting research 40
6.3.2 SINGLE-USE EQUIPMENT 40
6.3.2.1 Technological advancements & the increasing demand for biological products to drive market growth 40
6.3.3 OTHER EQUIPMENT 41
6.4 SYSTEMS & SOFTWARE 42
6.4.1 CELL THERAPY SYSTEMS & SOFTWARE ARE USED TO MONITOR THE DIFFERENT STAGES OF CELL PROCESSING 42
7 CELL THERAPY INSTRUMENTS MARKET, BY PROCESS 43
7.1 INTRODUCTION 44
7.2 CELL PROCESSING 45
7.2.1 CELL PROCESSING MAKES THE HIGHEST USE OF CELL THERAPY INSTRUMENTS, WHICH IS A MAJOR GROWTH DRIVER OF THIS SEGMENT 45
7.3 CELL PRESERVATION, DISTRIBUTION, AND HANDLING 46
7.3.1 DEMAND GROWTH FOR CELL-BASED MEDICAL PRODUCTS AND THERAPIES TO DRIVE THE MARKET FOR RELIABLE STORAGE EQUIPMENT 46
7.4 PROCESS MONITORING AND QUALITY CONTROL 47
7.4.1 PROCESS MONITORING IS ESSENTIAL TO ENSURE THE QUALITY AND ACCURACY OF CELL PROCESSING 47
8 CELL THERAPY INSTRUMENTS MARKET, BY CELL TYPE 48
8.1 INTRODUCTION 49
8.2 HUMAN CELLS 50
8.2.1 STEM CELLS 51
8.2.1.1 Investments from venture capitalists for stem cell research are a major factor driving the growth of this market 51
8.2.2 DIFFERENTIATED CELLS 52
8.2.2.1 Increasing investments from market players to develop new and innovative products is a key factor driving market growth 52
8.3 ANIMAL CELLS 53
8.3.1 GROWING INVESTMENTS IN ANIMAL CELL RESEARCH IS A MAJOR FACTOR DRIVING THE GROWTH OF THIS MARKET 53
 
9 CELL THERAPY INSTRUMENTS MARKET, BY END USER 54
9.1 INTRODUCTION 55
9.2 LIFE SCIENCE RESEARCH COMPANIES 56
9.2.1 INCREASING NUMBER OF CELL-BASED EXPERIMENTS AND DRUG DISCOVERY ACTIVITIES TO DRIVE MARKET GROWTH 56
9.3 RESEARCH INSTITUTES 57
9.3.1 GROWING RESEARCH ACTIVITIES SUPPORTING THE GROWTH OF THIS END-USER SEGMENT 57
10 CELL THERAPY INSTRUMENTS MARKET, BY REGION 58
10.1 INTRODUCTION 59
10.2 NORTH AMERICA 60
10.2.1 US 62
10.2.1.1 US will continue to dominate the North American cell therapy instruments market during the forecast period 62
10.2.2 CANADA 64
10.2.2.1 High burden of chronic diseases to drive the adoption of cell therapy instruments in Canada 64
10.3 EUROPE 66
10.3.1 GERMANY 68
10.3.1.1 Germany to be the fastest-growing market for cell therapy instruments in Europe 68
10.3.2 UK 69
10.3.2.1 Rising prevalence of NCDs in the UK to drive market growth 69
10.3.3 REST OF EUROPE 71
10.4 ASIA PACIFIC 73
10.4.1 CHINA 75
10.4.1.1 Increasing cell therapy-based research to support market growth in China 75
10.4.2 JAPAN 77
10.4.2.1 Increasing geriatric population and subsequent growth in the disease burden to support market growth in Japan 77
10.4.3 REST OF ASIA PACIFIC 79
10.5 REST OF THE WORLD 81
11 COMPETITIVE LANDSCAPE 83
11.1 OVERVIEW 83
11.2 MARKET PLAYERS RANKING ANALYSIS, 2017 84
11.2.1 TOP PLAYERS IN THE CELL THERAPY INSTRUMENTS MARKET 84
11.3 COMPETITIVE SCENARIO 85
 
12 COMPANY PROFILES 87
(Business overview, Products offered, Recent developments & MnM View)*
12.1 THERMO FISHER SCIENTIFIC, INC. 87
12.2 MERCK KGAA 90
12.3 TERUMO BCT, INC. (A SUBSIDIARY OF TERUMO CORPORATION) 93
12.4 LONZA GROUP 95
12.5 GE HEALTHCARE 97
12.6 SARTORIUS 100
12.7 BECTON, DICKINSON AND COMPANY 102
12.8 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION) 104
12.9 MILTENYI BIOTEC GMBH 106
12.10 STEMCELL TECHNOLOGIES 108
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
13 APPENDIX 110
13.1 INSIGHTS FROM INDUSTRY EXPERTS 110
13.2 DISCUSSION GUIDE 111
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 113
13.4 AVAILABLE CUSTOMIZATIONS 115
13.5 RELATED REPORTS 115
13.6 AUTHOR DETAILS 116